Knee joint effusion
A clinical reduction in symptoms was observed later in time in patients who had received chondroitin sulfate, but the symptoms did not reappear for up to 3 months after the end of treatment. knee joint effusion Knee joint effusion. A recent metaanalysisref 10 of seven studies including the two discussed above concluded that chondroitin sulfate may be useful in decreasing pain and improving function in osteoarthritis. Pooled data showed at least a 50% improvement in VAS pain scores and the Lequesne functional index. The pool consisted of 372 patients with OA of the hip or knee who had received chondroitin sulfate and 331 who had received placebo. knee joint effusion Thigh-pain. Patients were followed 120 or more days. In all of the studies, chondroitin sulfate was safe and there was no higher incidence of adverse events when compared to placebo. However, the metaanalysis was only comprised of seven studies, each of which examined a small number of patients. knee joint effusion Tuberculosis-arthritis. Thus, it is not possible to conclude anything more than that chondroitin sulfate may be useful in the treatment of osteoarthritis. Larger studies are needed to further examine the usefulness of chondroitin sulfate in osteoarthritis. No long-term studies examining the effect of chondroitin sulfate on radiographic progression are available. (top of section)(top of page) Magnetic Therapy A foundation of in vitro and clinical studies has demonstrated that electric and magnetic energy favorably affects disorders of dense connective tissue. These signals have become a fertile area of research in orthopedics and rheumatology.
Knee joint effusion
Clinics || Diagnosis-of-chest-pain || Sacroiliac-joint-pain || Signs-symptoms-of-osteoarthritis